Louise Wang Zhiying Humphrey

Array ( [id] => 18643467 [patent_doc_number] => 11767527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Modified oligonucleotides targeting SNPs [patent_app_type] => utility [patent_app_number] => 16/537374 [patent_app_country] => US [patent_app_date] => 2019-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 54 [patent_no_of_words] => 35801 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18643467 [patent_doc_number] => 11767527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Modified oligonucleotides targeting SNPs [patent_app_type] => utility [patent_app_number] => 16/537374 [patent_app_country] => US [patent_app_date] => 2019-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 54 [patent_no_of_words] => 35801 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18643467 [patent_doc_number] => 11767527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Modified oligonucleotides targeting SNPs [patent_app_type] => utility [patent_app_number] => 16/537374 [patent_app_country] => US [patent_app_date] => 2019-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 54 [patent_no_of_words] => 35801 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16537374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19410543 [patent_doc_number] => 12076335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Nucleic acids for inhibiting expression of TMPRSS6 and iron chelators [patent_app_type] => utility [patent_app_number] => 17/263090 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 57 [patent_no_of_words] => 40593 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15646647 [patent_doc_number] => 20200085853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => TARGETING NR3B1 FOR TREATMENT OF NASH [patent_app_type] => utility [patent_app_number] => 16/515970 [patent_app_country] => US [patent_app_date] => 2019-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16515970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15360759 [patent_doc_number] => 20200016144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => Method for Assessing the Efficacy of IMIDS and Composition or Combination for Use in Treating IMID Sensitive Diseases [patent_app_type] => utility [patent_app_number] => 16/515683 [patent_app_country] => US [patent_app_date] => 2019-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16515683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16013543 [patent_doc_number] => 20200181614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE [patent_app_type] => utility [patent_app_number] => 16/514815 [patent_app_country] => US [patent_app_date] => 2019-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16735896 [patent_doc_number] => 10961534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => Methods of treating porphyria [patent_app_type] => utility [patent_app_number] => 16/509734 [patent_app_country] => US [patent_app_date] => 2019-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 79 [patent_no_of_words] => 11536 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17112220 [patent_doc_number] => 20210292817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHODS FOR QUANTITATION OF ANALYTES IN MULTIPLEXED BIOCHEMICAL REACTIONS [patent_app_type] => utility [patent_app_number] => 17/258880 [patent_app_country] => US [patent_app_date] => 2019-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -160 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15455033 [patent_doc_number] => 20200040341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => MODULATORS OF DIACYGLYCEROL ACYLTRANSFERASE 2 (DGAT2) [patent_app_type] => utility [patent_app_number] => 16/456432 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14994353 [patent_doc_number] => 20190316134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => COMBINATION COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 16/450324 [patent_app_country] => US [patent_app_date] => 2019-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20356219 [patent_doc_number] => 12472198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => RIG-I agonists and treatments using same [patent_app_type] => utility [patent_app_number] => 17/251921 [patent_app_country] => US [patent_app_date] => 2019-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 46 [patent_no_of_words] => 20702 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17052596 [patent_doc_number] => 20210262030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => CIRCULATING MIRNAS AS BIOMARKERS FOR DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMERS DISEASE [patent_app_type] => utility [patent_app_number] => 17/252126 [patent_app_country] => US [patent_app_date] => 2019-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16946657 [patent_doc_number] => 20210205348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => Methods for the Treatment of Bladder Cancer [patent_app_type] => utility [patent_app_number] => 17/058817 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15020581 [patent_doc_number] => 20190321295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host [patent_app_type] => utility [patent_app_number] => 16/425990 [patent_app_country] => US [patent_app_date] => 2019-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23899 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15408555 [patent_doc_number] => 20200024599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => RNA INTERFERENCE FOR THE TREATMENT OF GAIN-OF-FUNCTION DISORDERS [patent_app_type] => utility [patent_app_number] => 16/415826 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16893419 [patent_doc_number] => 11034955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Chimeric double-stranded nucleic acid [patent_app_type] => utility [patent_app_number] => 16/410803 [patent_app_country] => US [patent_app_date] => 2019-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 50 [patent_no_of_words] => 25868 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16410803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14991651 [patent_doc_number] => 20190314783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => DE NOVO SYNTHESIZED GENE LIBRARIES [patent_app_type] => utility [patent_app_number] => 16/409608 [patent_app_country] => US [patent_app_date] => 2019-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116009 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16409608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16800437 [patent_doc_number] => 10995360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-04 [patent_title] => Use of aptamers in proteomics [patent_app_type] => utility [patent_app_number] => 16/406903 [patent_app_country] => US [patent_app_date] => 2019-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8972 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14712887 [patent_doc_number] => 20190247507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => BRANCHED OLIGONUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 16/390712 [patent_app_country] => US [patent_app_date] => 2019-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18372 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390712 [rel_patent_id] =>[rel_patent_doc_number] =>)